{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:49:54Z","timestamp":1783763394633,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.12.006","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T15:20:55Z","timestamp":1671636055000},"page":"724-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response"],"prefix":"10.1016","volume":"41","author":[{"given":"Emilio","family":"Siena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Schiavetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Borgogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Faenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Brazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Aprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Bardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Volpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Buricchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sammicheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Tavarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Bechtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Blohmke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Cardamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"De Intinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonzalez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek T.","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Seidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud M","family":"Didierlaurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bertholet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"D'Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duccio","family":"Medini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oretta","family":"Finco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"52","key":"10.1016\/j.vaccine.2022.12.006_b0005","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2016.10.016","article-title":"Vaccine development: From concept to early clinical testing","volume":"34","author":"Cunningham","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2022.12.006_b0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2022.12.006_b0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.coi.2010.04.004","article-title":"New adjuvants for human vaccines","volume":"22","author":"Mbow","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2022.12.006_b0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.12.006_b0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2022.12.006_b0030","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2019.07.098","article-title":"Adjuvant systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood","volume":"37","author":"Laup\u00e8ze","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.006_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the adjuvant system story","volume":"13","author":"Gar\u00e7on","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.12.006_b0040","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14760584.2021.1908133","article-title":"CpG-adjuvanted hepatitis B vaccine (HEPLISAV-B\u00ae) update","volume":"20","author":"Lee","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"10317","key":"10.1016\/j.vaccine.2022.12.006_b0045","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(21)02000-6","article-title":"Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial","volume":"398","author":"Ella","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.12.006_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.05.013","article-title":"Evolution of Toll-like receptor 7\/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants","volume":"175","author":"Bhagchandani","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2022.12.006_b0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1471-4906(02)02259-7","article-title":"Of mice and men: species variations of Toll-like receptor expression","volume":"23","author":"Rehli","year":"2002","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.006_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/srep29063","article-title":"Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines","volume":"6","author":"Buonsanti","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2022.12.006_b0065","doi-asserted-by":"crossref","unstructured":"Mancini F, Monaci E, Lofano G, Torre A, Bacconi M, Tavarini S, et al. One dose of Staphylococcus aureus 4C-Staph vaccine formulated with a novel TLR7-dependent adjuvant rapidly protects mice through antibodies, effector CD4+ T cells, and IL-17A. PLoS One 2016;11:e0147767. doi: 10.1371\/journal.pone.0147767.","DOI":"10.1371\/journal.pone.0147767"},{"issue":"112","key":"10.1016\/j.vaccine.2022.12.006_b0070","article-title":"A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model","volume":"18","author":"Hu","year":"2020","journal-title":"J Transl Med"},{"issue":"263","key":"10.1016\/j.vaccine.2022.12.006_b0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009980","article-title":"Rational design of small molecules as vaccine adjuvants","volume":"6","author":"Wu","year":"2014","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.vaccine.2022.12.006_b0080","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1073\/pnas.1424924112","article-title":"Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus","volume":"112","author":"Bagnoli","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2022.12.006_b0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fimmu.2018.00641","article-title":"Alum\/toll-like receptor 7 adjuvant enhances the expansion of memory B cell compartment within the draining lymph node","volume":"9","author":"Vo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.12.006_b0090","doi-asserted-by":"crossref","first-page":"108275","DOI":"10.1016\/j.clim.2019.108275","article-title":"Adjuvant effect of TLR7 agonist adsorbed on aluminum hydroxide (AS37): A phase I randomized, dose escalation study of an AS37-adjuvanted meningococcal C conjugated vaccine","volume":"209","author":"Gonzalez-Lopez","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2022.12.006_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00943","article-title":"Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans","volume":"8","author":"Burny","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.12.006_b0100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1198\/016214504000000683","article-title":"A model-based background adjustment for oligonucleotide expression arrays","volume":"99","author":"Wu","year":"2004","journal-title":"J Am Stat Assoc"},{"issue":"25","key":"10.1016\/j.vaccine.2022.12.006_b0105","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/bloodadvances.2017011411","article-title":"Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs","volume":"1","author":"Francica","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.vaccine.2022.12.006_b0110","doi-asserted-by":"crossref","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015;43:e47. doi: 10.1093\/nar\/gkv007.","DOI":"10.1093\/nar\/gkv007"},{"issue":"43","key":"10.1016\/j.vaccine.2022.12.006_b0115","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2022.12.006_b0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.006_b0125","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.immuni.2012.12.008","article-title":"Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines","volume":"38","author":"Obermoser","year":"2013","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.vaccine.2022.12.006_b0130","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1073\/pnas.0813390106","article-title":"Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"10.1016\/j.vaccine.2022.12.006_b0135","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1016\/j.vaccine.2012.04.020","article-title":"One dose of an MF59-adjuvanted pandemic A\/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies","volume":"30","author":"Faenzi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.006_b0140","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3389\/fimmu.2018.03047","article-title":"IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies","volume":"9","author":"Mogensen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.12.006_b0145","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2022.12.006_b0150","doi-asserted-by":"crossref","unstructured":"Spensieri F, Siena E, Borgogni E, Zedda L, Cantisani R, Chiappini N, et al. Early rise of blood T follicular helper cell subsets and baseline immunity as predictors of persisting late functional antibody responses to vaccination in humans. PLoS One 2016;11:e0157066. doi: 10.1371\/journal.pone.0157066.","DOI":"10.1371\/journal.pone.0157066"},{"key":"10.1016\/j.vaccine.2022.12.006_b0155","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","article-title":"Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production","volume":"192","author":"Breitfeld","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2022.12.006_b0160","doi-asserted-by":"crossref","first-page":"E488","DOI":"10.1073\/pnas.1100898108","article-title":"Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers","volume":"108","author":"Bentebibel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2022.12.006_b0165","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.192.11.1553","article-title":"CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function","volume":"192","author":"Schaerli","year":"2000","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.006_b0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"issue":"176","key":"10.1016\/j.vaccine.2022.12.006_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci Transl Med"},{"issue":"35","key":"10.1016\/j.vaccine.2022.12.006_b0180","doi-asserted-by":"crossref","first-page":"14330","DOI":"10.1073\/pnas.1311998110","article-title":"Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses","volume":"110","author":"Spensieri","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.006_b0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2022.12.006_b0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12977-017-0380-3","article-title":"Systems serology: profiling vaccine induced humoral immunity against HIV","volume":"14","author":"Chung","year":"2017","journal-title":"Retrovirology"},{"key":"10.1016\/j.vaccine.2022.12.006_b0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clim.2016.05.007","article-title":"Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: results from a phase II, randomized, multicenter trial","volume":"169","author":"Leroux-Roels","year":"2016","journal-title":"Clin Immunol"},{"issue":"7862","key":"10.1016\/j.vaccine.2022.12.006_b0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.12.006_b0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-004-0180-4","article-title":"Plasmacytoid dendritic cell precursors\/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9","volume":"26","author":"Ito","year":"2005","journal-title":"Springer Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.006_b0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:20:42Z","timestamp":1759404042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22015195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22015195"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}